Kennedy Capital Management Llc

Source: SEC Form 13F · as of Mar 2026

Kennedy Capital Management Llc holds 93 biotech & pharma companies tracked by BioSniper, totaling $607.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

93

Total value held

$607.9M

CompanySharesValue
GMEDGlobus Medical Inc.460,292$39.7M
HALOHALOZYME THERAPEUTICS, INC.484,580$31.3M
CPRXCATALYST PHARMACEUTICALS, INC.1,199,598$29.7M
ANIPANI PHARMACEUTICALS INC293,996$22.6M
LLYELI LILLY & Co19,732$18.1M
NATRNATURES SUNSHINE PRODUCTS INC691,498$16.6M
ICUIICU Medical Inc.125,977$16.3M
PTGXProtagonist Therapeutics, Inc137,099$14.5M
ABBVAbbVie Inc.64,980$14.1M
COGTCogent Biosciences, Inc.360,490$13.9M
JNJJOHNSON & JOHNSON56,640$13.8M
NEOGNEOGEN CORP1,447,497$13.4M
NAMSNEWAMSTERDAM PHARMA CO N.V.408,492$13.1M
ADPTAdaptive Biotechnologies Corp931,522$12.9M
GILDGILEAD SCIENCES, INC.91,264$12.7M
CORTCORCEPT THERAPEUTICS INC304,615$12.3M
CLDXCelldex Therapeutics, Inc.352,302$11.2M
APGEApogee Therapeutics, Inc.122,669$10.3M
VRTXVERTEX PHARMACEUTICALS INC / MA22,994$10.3M
MRKMerck & Co., Inc.78,744$9.5M
DAWNDay One Biopharmaceuticals, Inc.436,732$9.4M
AGIOAGIOS PHARMACEUTICALS, INC.275,456$9.3M
TECXTectonic Therapeutic, Inc.286,682$8.9M
NRIXNurix Therapeutics, Inc.561,250$8.7M
IONSIONIS PHARMACEUTICALS INC111,830$8.4M
EWTXEdgewise Therapeutics, Inc.264,204$8.3M
RAPPRapport Therapeutics, Inc.257,431$8.1M
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.43,634$7.5M
MGTXMeiraGTx Holdings plc858,379$7.4M
NBIXNEUROCRINE BIOSCIENCES INC55,055$7.3M
XERSXeris Biopharma Holdings, Inc.1,240,692$7.2M
IRONDisc Medicine, Inc.108,286$6.9M
IMNMImmunome Inc.287,030$6.3M
AXSMAxsome Therapeutics, Inc.36,775$6.2M
ORKAOruka Therapeutics, Inc.126,366$6.2M
ABTABBOTT LABORATORIES59,473$6.1M
ARVNARVINAS, INC.552,641$5.9M
AVTXAvalo Therapeutics, Inc.387,982$5.8M
RYTMRHYTHM PHARMACEUTICALS, INC.65,818$5.7M
AZNASTRAZENECA PLC28,837$5.7M
PBYIPUMA BIOTECHNOLOGY, INC.889,601$5.7M
ABEOABEONA THERAPEUTICS INC.1,263,511$5.7M
INSMINSMED Inc34,526$5.6M
UNHUnitedHealth Group Incorporated Common Stock (DE)18,880$5.1M
ANNXAnnexon, Inc.912,323$5.1M
INBXInhibrx Biosciences, Inc.72,812$4.9M
RAREUltragenyx Pharmaceutical Inc.219,291$4.6M
SOPHSOPHiA GENETICS SA927,800$4.6M
CRMDCorMedix Inc.673,302$4.6M
BVSBioventus Inc.474,971$4.3M
PARKPark Dental Partners Inc.241,257$4.0M
GEHCGE HealthCare Technologies Inc.55,917$4.0M
RZLTRezolute, Inc.1,236,098$3.8M
WVEWave Life Sciences Ltd.519,768$3.8M
ZYMEZymeworks Inc.148,226$3.7M
ADMAADMA BIOLOGICS, INC.411,347$3.7M
INCYIncyte Corp.36,429$3.4M
ROIVRoivant Sciences Ltd.121,897$3.4M
ARGXARGENX SE4,577$3.3M
JAZZJazz Pharmaceuticals plc17,603$3.3M
DSGNDesign Therapeutics, Inc.271,554$2.9M
EDITEditas Medicine, Inc.1,052,457$2.6M
BMYBRISTOL MYERS SQUIBB CO35,799$2.2M
AMGNAMGEN INC5,955$2.1M
BNTXBioNTech SE21,913$1.9M
TLSITriSalus Life Sciences Inc.485,242$1.9M
SRRKScholar Rock Holding Corp37,452$1.8M
BIIBBIOGEN INC.9,808$1.8M
SNYSanofi36,982$1.8M
ABUSArbutus Biopharma Corp393,132$1.8M
ICLRICON plc15,648$1.7M
KRYSKrystal Biotech, Inc.4,904$1.3M
NUVLNuvalent, Inc.11,909$1.2M
CORCencora Inc.3,776$1.2M
IQVIQVIA Holdings Inc.6,822$1.2M
ALNYALNYLAM PHARMACEUTICALS, INC.3,503$1.2M
KYMRKymera Therapeutics, Inc.13,661$1.1M
ZTSZoetis Inc.8,496$1.0M
ABVXAbivax SA8,757$975K
CYTKCYTOKINETICS INC14,361$947K
SYRESpyre Therapeutics, Inc.16,873$851K
CGEMCullinan Therapeutics, Inc.51,491$732K
TRVITrevi Therapeutics, Inc.61,298$731K
MMSIMerit Medical Systems Inc.10,384$716K
VTRSViatris Inc46,257$625K
ELVElevance Health Inc.1,888$553K
GLUEMonte Rosa Therapeutics, Inc.31,977$526K
SIONSionna Therapeutics, Inc.12,284$492K
MDXHMDxHealth SA205,438$473K
RNAAtrium Therapeutics Inc.33,977$454K
CADLCandel Therapeutics, Inc.92,625$454K
NTLAIntellia Therapeutics, Inc.29,424$377K
ALDXAldeyra Therapeutics, Inc.95,862$162K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.